Latest / Salt Lake City News Today | 2 Min News | The Daily News Now!
Melanoma Vaccine Shows Promise | Salt Lake City News
Merck and Moderna just dropped big news: their new personalized melanoma vaccine, intismeran, is showing major promise in a massive phase three trial — slashing the risk of cancer recurrence when paired with Keytruda. This breakthrough, targeting unique tumor mutations called neoantigens, could redefine melanoma treatment — the deadliest form of skin cancer affecting over 1.5 million Americans. Early data from phase two hinted at nearly 50% reduced recurrence, with mostly mild side effects. Moderna’s CEO even likened the potential impact to their COVID vaccine launch — calling it a new…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.